Table 3. Demographic and clinical characteristics of patients with confirmed Fabry Disease (FD).
Age of diagnosis of FD (years) | Age of first presentation (years) | Initial presentation | ECG data | ERT | Baseline septal wall thickness (mm) | Septal wall thickness at 6 months after ERT commencement (mm) |
---|---|---|---|---|---|---|
74 | 71 | Incidental murmur; aortic regurgitation | RBBB | No | 19 | 19 |
59 | 54 | Chest pain on exertion | LVH | Yes | 19 | 18 |
59 | 59 | Found LVH on echo during evaluation for AF | AF, nonspecific intraventricular conduction delay; inferior infarct | Yes | 24 | 18.5 |
62 | 61 | Atypical chest pain and recurrent syncope | AF, LVH; 2:1 AV block (requiring pacemaker) | No | 13 | 17 |
61 | 42 | Hypertension and LVH on echo | LVH | No | 17 | 23 |
FD indicates Fabry Disease; ECG, electrocardiogram; ERT, enzyme replacement therapy; RBBB, right bundle branch block; LVH, left ventricular hypertrophy; AF, atrial fibrillation; AV, atrioventricular.